Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.96 USD | -0.92% | -5.58% | -9.30% |
May. 07 | Sector Update: Health Care Stocks Steady Pre-Bell Tuesday | MT |
May. 07 | Transcript : Intra-Cellular Therapies, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 663M | Sales 2025 * | 924M | Capitalization | 6.86B |
---|---|---|---|---|---|
Net income 2024 * | -56M | Net income 2025 * | 91M | EV / Sales 2024 * | 9.03 x |
Net cash position 2024 * | 872M | Net cash position 2025 * | 926M | EV / Sales 2025 * | 6.42 x |
P/E ratio 2024 * |
-113
x | P/E ratio 2025 * |
67.7
x | Employees | 610 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.58% |
Latest transcript on Intra-Cellular Therapies, Inc.
1 day | -0.92% | ||
1 week | -5.58% | ||
Current month | -9.54% | ||
1 month | -3.45% | ||
3 months | -10.73% | ||
6 months | +21.51% | ||
Current year | -9.30% |
Managers | Title | Age | Since |
---|---|---|---|
Sharon Mates
CEO | Chief Executive Officer | 71 | 13-08-28 |
Director of Finance/CFO | 67 | 13-08-28 | |
Michael Halstead
PSD | President | 51 | 14-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rory Riggs
BRD | Director/Board Member | 71 | 14-01-07 |
Joel Marcus
BRD | Director/Board Member | 76 | 13-08-28 |
Director/Board Member | 67 | 14-01-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.14% | 0 M€ | -4.02% | ||
0.45% | 0 M€ | 0.00% | - | |
0.40% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 64.96 | -0.92% | 730,757 |
24-05-09 | 65.56 | -2.15% | 767,145 |
24-05-08 | 67 | -5.91% | 994,208 |
24-05-07 | 71.21 | +0.28% | 1,128,033 |
24-05-06 | 71.01 | +3.21% | 750,134 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.30% | 6.92B | |
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-14.40% | 32.43B | |
+55.89% | 24.28B | |
-15.96% | 15.52B | |
-41.29% | 12.17B | |
-15.50% | 12.01B | |
-11.75% | 12B | |
+7.87% | 8.87B |
- Stock Market
- Equities
- ITCI Stock